| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| DIELDRIN | TOX-REPRO - development | total body weight, compared to control | no effect | 4-6/dose | Juvenile | 8 d | Toxicity Factor Datasets |
| DIELDRIN | TOX-EXP IND - accumulation | mean of day 5, 7, 8 (approx. steady state) tissue concentrations | 9.7 ug/g lipid, 3.3 ug/g skin, 1.3 ug/g brain, 0.8 ug/g liver, 0.7 ug/g muscle at 2.6 ug/g food | 6 | Juvenile | 8 d | Toxicity Factor Datasets |
| DIELDRIN | TOX-EXP IND - accumulation | mean of day 5, 7, 8 (approx. steady state) tissue concentrations | 42.5 ug/g lipid, 14.6 ug/g skin, 1.6 ug/g brain, 2.5 ug/g liver, 1.2 ug/g muscle at 26.2 ug/g food | 6 | Juvenile | 8 d | Toxicity Factor Datasets |
| DIELDRIN | TOX-EXP IND - accumulation | mean of day 5, 7, 8 (approx. steady state) tissue concentrations | 80.7 ug/g lipid, 30.1 ug/g skin, 1.6 ug/g brain, 4.1 ug/g liver, 1.8 ug/g muscle at 49.3 ug/g food | 6 | Juvenile | 8 d | Toxicity Factor Datasets |
